State of Wisconsin Investment Board
GYRE icon

State of Wisconsin Investment Board’s Gyre Therapeutics GYRE Stock Holding History

State of Wisconsin Investment Board’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,800
Closed -$175K – 2546
2025
Q4 		$175K Sell
24,800
-14,200
-36% -$110K ﹤0.01% 2285
2025
Q3 		$291K Buy
39,000
+1,330
+4% +$10.1K ﹤0.01% 2122
2025
Q2 		$277K Buy
+37,670
New +$329K ﹤0.01% 2093
2019
Q2 		– Sell
-2,147
Closed -$131K – 1563
2019
Q1 		$131K Buy
2,147
+480
+29% +$30.8K ﹤0.01% 1492
2018
Q4 		$99K Buy
+1,667
New +$123K ﹤0.01% 1496

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State of Wisconsin Investment Board's GYRE Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Gyre Therapeutics (GYRE) in Q1 2026, closing a stake of 24,800 shares — an estimated $175K sold.

State of Wisconsin Investment Board first reported a position in GYRE in Q4 2018 and held it in 5 quarters. The position peaked at $291K in Q3 2025. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Gyre Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 24,800 Gyre Therapeutics shares in Q1 2026, an estimated $175K.
  • State of Wisconsin Investment Board first reported a position in Gyre Therapeutics in Q4 2018 and held it in 5 quarters.
  • State of Wisconsin Investment Board's Gyre Therapeutics position peaked at $291K in Q3 2025.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.